256 related articles for article (PubMed ID: 34504101)
1. TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growth.
Chan TY; Egbert CM; Maxson JE; Siddiqui A; Larsen LJ; Kohler K; Balasooriya ER; Pennington KL; Tsang TM; Frey M; Soderblom EJ; Geng H; Müschen M; Forostyan TV; Free S; Mercenne G; Banks CJ; Valdoz J; Whatcott CJ; Foulks JM; Bearss DJ; O'Hare T; Huang DCS; Christensen KA; Moody J; Warner SL; Tyner JW; Andersen JL
Nat Commun; 2021 Sep; 12(1):5337. PubMed ID: 34504101
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the tyrosine kinase Tnk1 and its binding with phospholipase C-gamma1.
Felschow DM; Civin CI; Hoehn GT
Biochem Biophys Res Commun; 2000 Jun; 273(1):294-301. PubMed ID: 10873601
[TBL] [Abstract][Full Text] [Related]
3. Identification of activated Tnk1 kinase in Hodgkin's lymphoma.
Gu TL; Cherry J; Tucker M; Wu J; Reeves C; Polakiewicz RD
Leukemia; 2010 Apr; 24(4):861-5. PubMed ID: 20090780
[No Abstract] [Full Text] [Related]
4. Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells.
Wossning T; Herzog S; Köhler F; Meixlsperger S; Kulathu Y; Mittler G; Abe A; Fuchs U; Borkhardt A; Jumaa H
J Exp Med; 2006 Dec; 203(13):2829-40. PubMed ID: 17130299
[TBL] [Abstract][Full Text] [Related]
5. Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway.
Wang X; Yang J; Guo G; Feng R; Chen K; Liao Y; Zhang L; Sun L; Huang S; Chen JL
Mol Cancer; 2019 Apr; 18(1):84. PubMed ID: 30961617
[TBL] [Abstract][Full Text] [Related]
6. Thirty-eight-negative kinase 1 mediates trauma-induced intestinal injury and multi-organ failure.
Armacki M; Trugenberger AK; Ellwanger AK; Eiseler T; Schwerdt C; Bettac L; Langgartner D; Azoitei N; Halbgebauer R; Groß R; Barth T; Lechel A; Walter BM; Kraus JM; Wiegreffe C; Grimm J; Scheffold A; Schneider MR; Peuker K; Zeißig S; Britsch S; Rose-John S; Vettorazzi S; Wolf E; Tannapfel A; Steinestel K; Reber SO; Walther P; Kestler HA; Radermacher P; Barth TF; Huber-Lang M; Kleger A; Seufferlein T
J Clin Invest; 2018 Nov; 128(11):5056-5072. PubMed ID: 30320600
[TBL] [Abstract][Full Text] [Related]
7. Tnk1/Kos1: a novel tumor suppressor.
May WS; Hoare K; Hoare S; Reinhard MK; Lee YJ; Oh SP
Trans Am Clin Climatol Assoc; 2010; 121():281-92; discussion 292-3. PubMed ID: 20697568
[TBL] [Abstract][Full Text] [Related]
8. Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia.
Gleixner KV; Schneeweiss M; Eisenwort G; Berger D; Herrmann H; Blatt K; Greiner G; Byrgazov K; Hoermann G; Konopleva M; Waliul I; Cumaraswamy AA; Gunning PT; Maeda H; Moriggl R; Deininger M; Lion T; Andreeff M; Valent P
Haematologica; 2017 Sep; 102(9):1519-1529. PubMed ID: 28596283
[TBL] [Abstract][Full Text] [Related]
9. Fusion crystallization reveals the behavior of both the 1TEL crystallization chaperone and the TNK1 UBA domain.
Nawarathnage S; Tseng YJ; Soleimani S; Smith T; Pedroza Romo MJ; Abiodun WO; Egbert CM; Madhusanka D; Bunn D; Woods B; Tsubaki E; Stewart C; Brown S; Doukov T; Andersen JL; Moody JD
Structure; 2023 Dec; 31(12):1589-1603.e6. PubMed ID: 37776857
[TBL] [Abstract][Full Text] [Related]
10. Novel antiviral host factor, TNK1, regulates IFN signaling through serine phosphorylation of STAT1.
Ooi EL; Chan ST; Cho NE; Wilkins C; Woodward J; Li M; Kikkawa U; Tellinghuisen T; Gale M; Saito T
Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1909-14. PubMed ID: 24449862
[TBL] [Abstract][Full Text] [Related]
11. The noncatalytic regions of the tyrosine kinase Tnk1 are important for activity and substrate specificity.
Ahmed S; Miller WT
J Biol Chem; 2022 Dec; 298(12):102664. PubMed ID: 36334623
[TBL] [Abstract][Full Text] [Related]
12. Rationally designed aberrant kinase-targeted endogenous protein nanomedicine against oncogene mutated/amplified refractory chronic myeloid leukemia.
Retnakumari AP; Hanumanthu PL; Malarvizhi GL; Prabhu R; Sidharthan N; Thampi MV; Menon D; Mony U; Menon K; Keechilat P; Nair S; Koyakutty M
Mol Pharm; 2012 Nov; 9(11):3062-78. PubMed ID: 22971013
[TBL] [Abstract][Full Text] [Related]
13. Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.
Eiring AM; Page BDG; Kraft IL; Mason CC; Vellore NA; Resetca D; Zabriskie MS; Zhang TY; Khorashad JS; Engar AJ; Reynolds KR; Anderson DJ; Senina A; Pomicter AD; Arpin CC; Ahmad S; Heaton WL; Tantravahi SK; Todic A; Moriggl R; Wilson DJ; Baron R; O'Hare T; Gunning PT; Deininger MW
Leukemia; 2015 Mar; 29(3):586-597. PubMed ID: 25134459
[TBL] [Abstract][Full Text] [Related]
14. Targeting STAT5 or STAT5-Regulated Pathways Suppresses Leukemogenesis of Ph+ Acute Lymphoblastic Leukemia.
Minieri V; De Dominici M; Porazzi P; Mariani SA; Spinelli O; Rambaldi A; Peterson LF; Porcu P; Nevalainen MT; Calabretta B
Cancer Res; 2018 Oct; 78(20):5793-5807. PubMed ID: 30154155
[TBL] [Abstract][Full Text] [Related]
15. Tnk1: a novel intracellular tyrosine kinase gene isolated from human umbilical cord blood CD34+/Lin-/CD38- stem/progenitor cells.
Hoehn GT; Stokland T; Amin S; Ramírez M; Hawkins AL; Griffin CA; Small D; Civin CI
Oncogene; 1996 Feb; 12(4):903-13. PubMed ID: 8632913
[TBL] [Abstract][Full Text] [Related]
16. CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine.
Gu Y; Chen T; Meng Z; Gan Y; Xu X; Lou G; Li H; Gan X; Zhou H; Tang J; Xu G; Huang L; Zhang X; Fang Y; Wang K; Zheng S; Huang W; Xu R
Blood; 2012 Dec; 120(24):4829-39. PubMed ID: 23074277
[TBL] [Abstract][Full Text] [Related]
17. Polyphenol tri-vanillic ester 13c inhibits P-JAK2V617F and Bcr-Abl oncokinase expression in correlation with STAT3/STAT5 inactivation and apoptosis induction in human leukemia cells.
Trécul A; Morceau F; Gaigneaux A; Orsini M; Chateauvieux S; Grandjenette C; Dicato M; Diederich M
Cancer Lett; 2013 Oct; 340(1):30-42. PubMed ID: 23811288
[TBL] [Abstract][Full Text] [Related]
18. Dual phosphorylation of Btk by Akt/protein kinase b provides docking for 14-3-3ζ, regulates shuttling, and attenuates both tonic and induced signaling in B cells.
Mohammad DK; Nore BF; Hussain A; Gustafsson MO; Mohamed AJ; Smith CI
Mol Cell Biol; 2013 Aug; 33(16):3214-26. PubMed ID: 23754751
[TBL] [Abstract][Full Text] [Related]
19. Thirty-Eight-Negative Kinase 1 Is a Mediator of Acute Kidney Injury in Experimental and Clinical Traumatic Hemorrhagic Shock.
Halbgebauer R; Karasu E; Braun CK; Palmer A; Braumüller S; Schultze A; Schäfer F; Bückle S; Eigner A; Wachter U; Radermacher P; Resuello RRG; Tuplano JV; Nilsson Ekdahl K; Nilsson B; Armacki M; Kleger A; Seufferlein T; Kalbitz M; Gebhard F; Lambris JD; van Griensven M; Huber-Lang M
Front Immunol; 2020; 11():2081. PubMed ID: 32983160
[TBL] [Abstract][Full Text] [Related]
20. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
